NYSE:USNA

USANA Health Sciences (USNA) Stock Price, News & Analysis

USANA Health Sciences logo
$12.98 -0.18 (-1.38%)
Closing price 11/20/2026 03:59 PM Eastern
Extended Trading
$13.25 +0.27 (+2.10%)
As of 11/20/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About USANA Health Sciences Stock (NYSE:USNA)

Advanced

Key Stats

Today's Range
$12.88
▼
$13.43
50-Day Range
$12.70
▼
$15.48
52-Week Range
$12.52
▼
$23.59
Volume
158,780 shs
Average Volume
204,403 shs
Market Capitalization
$239.96 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Sell

Company Overview

USANA Health Sciences, Inc. develops and sells nutritional supplements, personal care products and foods. Its offerings include vitamins and other nutrition products, skincare products under the Celavive brand, and nutrition bars.

Founded in 1992 by Myron Wentz, the company uses a direct-selling model, with independent Associates and other sales channels connecting its products with customers. USANA serves markets across North America, Asia-Pacific and other international regions.

AI Generated. May Contain Errors.

USANA Health Sciences Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
19th Percentile Overall Score

USNA MarketRank™: 
0.94566425792 of 5 stars

USANA Health Sciences scored higher than 19% of companies evaluated by MarketBeat, and ranked 142nd out of 167 stocks in the consumer staples sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    USANA Health Sciences has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 2 sell ratings.

  • Amount of Analyst Coverage

    USANA Health Sciences has only been the subject of 2 research reports in the past 90 days.

  • Read more about USANA Health Sciences' stock forecast and price target.
  • Earnings Growth

    Earnings for USANA Health Sciences are expected to grow by 127.27% in the coming year, from $0.55 to $1.25 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of USANA Health Sciences is -11.29, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of USANA Health Sciences is -11.29, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Growth Ratio

    USANA Health Sciences has a PEG Ratio of 2.05. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    USANA Health Sciences has a P/B Ratio of 0.46. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    4.80% of the float of USANA Health Sciences has been sold short.
  • Short Interest Ratio / Days to Cover

    USANA Health Sciences has a short interest ratio ("days to cover") of 5.15.
  • Change versus previous month

    Short interest in USANA Health Sciences has recently increased by 12.86%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    USANA Health Sciences does not currently pay a dividend.

  • Dividend Growth

    USANA Health Sciences does not have a long track record of dividend growth.

  • MarketBeat Follows

    1 people have added USANA Health Sciences to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, USANA Health Sciences insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    0.82% of the stock of USANA Health Sciences is held by insiders.

  • Percentage Held by Institutions

    54.25% of the stock of USANA Health Sciences is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about USANA Health Sciences' insider trading history.
Receive USNA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for USANA Health Sciences and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

USNA Stock News Headlines

USANA Health Sciences (USNA) Stock Falls on Q3 2026 Earnings
USANA Health Sciences FY2027 Earnings Forecast Cut by Sidoti
ELON + YOU + DECEMBER 8TH
Elon Musk's next big project may be the most ambitious move of his career, and all signs point to December 8th. A free Masterclass claims to reveal what Musk filed with regulators and why he's working to keep it quiet.tc pixel
USANA (USNA) Q3 2026 Earnings Call Transcript
See More Headlines

USNA Stock Analysis - Frequently Asked Questions

USANA Health Sciences' stock was trading at $19.61 at the beginning of the year. Since then, USNA stock has decreased by 33.8% and is now trading at $12.9780.

USANA Health Sciences, Inc. (NYSE:USNA) issued its earnings results on Tuesday, November, 3rd. The company reported ($0.11) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.11 by $0.22. The company had revenue of $205.89 million for the quarter, compared to analyst estimates of $217.42 million. USANA Health Sciences had a positive trailing twelve-month return on equity of 3.56% and a negative net margin of 2.34%.
Read the conference call transcript
.

Top institutional investors of USANA Health Sciences include Pzena Investment Management LLC (6.03%), Nantahala Capital Management LLC (5.35%), State Street Corp (1.32%) and American Century Companies Inc. (1.01%). Insiders that own company stock include Myron W Wentz, Jim Brown, Kevin Guest, David Mulham Mulham, Frederic J Winssinger, John Turman Fleming, Peggie Pelosi, Walter Noot, Robert A Sinnott, Paul A Jones, Joshua Foukas, Gilbert A Fuller, G Doug Iiekking, Daniel A Macuga and Brent Neidig.
View institutional ownership trends
.

Shares of USNA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that USANA Health Sciences investors own include NVIDIA (NVDA), Nu Skin Enterprises (NUS), Procter & Gamble (PG), Herbalife (HLF), International Business Machines (IBM), Tesla (TSLA) and Best Buy (BBY).

Company Calendar

Last Earnings
11/03/2026
Today
11/21/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Personal Care Products
Sub-Industry
Personal Care Products
Current Symbol
NYSE:USNA
CIK
896264
Employees
1,570
Year Founded
1992

Profitability

EPS (Trailing Twelve Months)
($1.15)
Trailing P/E Ratio
N/A
Forward P/E Ratio
10.38
P/E Growth
2.05
Net Income
$10.76 million
Net Margins
-2.34%
Pretax Margin
-0.01%
Return on Equity
3.56%
Return on Assets
2.62%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.59
Quick Ratio
1.84

Sales & Book Value

Annual Sales
$925.26 million
Price / Sales
0.26
Cash Flow
$3.96 per share
Price / Cash Flow
3.28
Book Value
$28.49 per share
Price / Book
0.46

Miscellaneous

Outstanding Shares
18,490,000
Free Float
18,337,000
Market Cap
$239.96 million
Optionable
Optionable
Beta
0.66

Social Links

7 Energy Stocks to Buy and Hold Forever Cover

Oil still powers the global economy, but AI is reshaping the energy opportunity. Discover seven stocks spanning traditional energy, infrastructure, and next-generation power.

Get This Free Report

This page (NYSE:USNA) was last updated on 11/20/2026 by MarketBeat.com Staff.
From Our Partners